Articles tagged as 'ADRs'

20 results

Three questions on… desogestrel and panic attacks
UMC’s Research pharmacist Sarah Watson explains the significance of a recently published signal that links contraceptive drug desogestrel to panic attacks.

A thinker outside of the box
UMC pays homage to a trailblazer in pharmacovigilance, Dr. Ed Napke.

Ukraine remains focused on ensuring medicine safety for its citizens
Despite an ongoing war and the destruction of more than 100 healthcare facilities, Ukraine’s pharmacovigilance system remains fully functional.

Making medicines safer for pregnant and breastfeeding women
Pregnancy and breastfeeding can be a chaotic period, exacerbated by lack of safety information for drugs taken during this time. The IMI ConcePTION project aims to change that.

Start small, but think big: Trials and triumphs of #MedSafetyWeek campaigners
As we prepare for the eighth rendition of the #MedSafetyWeek campaign, we talk to some seasoned campaigners on how to run a successful campaign.

Empowering Patients as Partners: Patient Engagement in Healthcare
A patient’s perspective is powerful in ensuring safe medical care. Yet how may we best harness their perspective to improve patient outcomes?

Guardians of Health: Vigilant surveillance of HIV and TB medicines in Namibia
The introduction of new medications for HIV and TB in Namibia required a more proactive hand in monitoring their safety. For the Namibian TWG, active surveillance was the answer.

ASCEND project’s success leads to a sharp rise in ADR reporting in Tanzania
The project epitomises the value of going digital and working together with each other and the community to strengthen pharmacovigilance systems.

Reforming pharmacovigilance education – New podcast out now
Lack of knowledge on reporting and adverse drug reactions in general greatly impact pharmacovigilance, yet how may education be improved to tackle this?

Hey researcher, what are you reading?
A UMC researcher reviews a book that examines the French pharmacovigilance system through the eyes of patients affected by adverse drug reactions.